The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.
- Published in:
- Advanced Pharmaceutical Bulletin, 2021, v. 11, n. 1, p. 188
- By:
- Publication type:
- Article